Clinical Trials Directory

Trials / Completed

CompletedNCT05737862

Effect of Moringa Oleifera Leaf on Hemoglobin Levels in Anemia

Effect of Moringa Oleifera Leaf Capsul on Hemoglobin Levels in Anemia: A Pilot Study

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Universitas Padjadjaran · Academic / Other
Sex
Female
Age
15 Years – 50 Years
Healthy volunteers
Accepted

Summary

The main objective of this study was to compare the results of hemoglobin levels between pregnant women in the treatment group and the control group. Participants will be subjected to anthropometric measurements, recall of food intake for 1 x 24 hours, check hemoglobin before and after being given the intervention and participants in the treatment group are given moringa leaf capsules and iron tablets while participants in the control group are only given iron tablets. Researchers will compare the final results of hemoglobin levels between the treatment group and the control group

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMoringa oleifera capsulesIn this arm, pregnant mothers receive capsules containing 500 mg of powdered Moringa oleifera leaves which contain 13.09 mg of iron per100 gram. Dose: 2 × 2 capsules per day for 30 days
DIETARY_SUPPLEMENTiron and folic acid supplementsIn this arm, pregnant mothers receive IFA tablets 2 × 1 tablet a day for 30 days. Each IFA tablet contains 400 mcg folic acid and 180 mg Ferrous Fumarate.

Timeline

Start date
2022-04-01
Primary completion
2022-06-30
Completion
2022-07-30
First posted
2023-02-21
Last updated
2023-03-09

Locations

1 site across 1 country: Indonesia

Source: ClinicalTrials.gov record NCT05737862. Inclusion in this directory is not an endorsement.